The Gene Panel Market is being driven by Growing use of gene panels in cancer-targeted therapies
The Gene Panel Market is expected to grow at a CAGR of 23.44% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 5403.9 million. In the dynamic and cost-pressured life sciences tools and services market, strategic alliances have emerged as a popular business strategy for gene panel vendors. These collaborations, which span the value chain, enable vendors to tackle challenges in research, manufacturing, and commercialization. Notably, Agilent Technologies Inc., a leading player in the gene panel market, entered into a Memorandum of Understanding (MOU) with Theragen Bio in South Korea in April 2023, marking a significant technology transfer agreement.
Get more information on Gene Panel Market by requesting a sample report
The market is segmented based on
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
However, the market also witnesses some limitations, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Market Scope |
|
Report Coverage |
Details |
Page number |
170 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 23.44% |
Market growth 2024-2028 |
USD 5403.9 million |
Market structure |
fragmentation |
YoY growth 2023-2024(%) |
18.67 |
Key countries |
US, Germany, UK, China, and France |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Find out which segment is leading the market by accessing the free PDF report
In the realm of personalized medicine, the gene panel market holds significant importance in addressing the complexities of multiple chronic conditions among adults. These conditions encompass various therapeutic areas such as arthritis, diabetes, cardiovascular diseases, and oncology. Genetic composition plays a crucial role in disease prognostics and mortality rates, making genetic testing essential. Gene panels, a subset of genetic testing, enable the identification of genetic alterations linked to hereditary disorders, including monogenic defects and diagnosed genetic conditions. Genomics and sequencing technologies facilitate the analysis of genes and gene panels, providing valuable insights into genetic predisposition and cancer rates. Clinicians utilize this information to tailor therapeutics and improve patient outcomes. Gene panels are instrumental in the diagnosis and management of genetic disorders, ultimately contributing to the advancement of disease-specific therapeutics and disease prevention strategies.
In the global gene panel market, companies specializing in research and development of diagnostic tools and services are of significant interest. This market encompasses capital equipment, instruments, accessories, and consumables used for gene research in pharmaceuticals and biotechnology. Additionally, it includes contract research, manufacturing, and sales services. According to Technavio, the gene panel market size is determined by the collective revenue generated by these entities. Factors fueling market expansion include the increasing aging population, with the global population over 60 predicted to rise substantially.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted